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Objectives: The objectives of the study were to formulate herbospheres of V. amygdalina leaf-extract and to study the in vitro and antibacterial 
properties of the formulations.
Methods: Herbospheres were formulated with lipid matrices consisting of goat fat (70%) and Phospholipon® 90H (30%) by melt homogenization 
and characterized for taste masking, particle size, pH, encapsulation efficiency, and loading capacity. Inhibition zone diameter of the herbospheres 
was studied.
Results: Phytochemical analysis showed the presence of alkaloids, saponins, tannins, carbohydrates, reducing sugars, protein, steroids, flavonoids, 
and cardiac glycosides in substantial quantities. Acid compounds and oils were, however, absent. The particle size of herbospheres ranged from 
6.90±0.2 to 28.50±0.71 µm and was significantly affected by the type of surfactant used (p < 0.05). The pH ranged from 5.6 to 5.9 at day 1 and 4.1 to 
4.4 at 30 days. Highest EE of 90–92 % was obtained and was significantly affected by surfactant used (p<0.05). Formulations exhibited significantly 
higher inhibition of Staphylococcus aureus than tetracycline pure sample used as the reference drug (p<0.05).
Conclusion: V. amygdalina herbospheres formulations had antibacterial properties in addition to taste masking and high encapsulation of the extract.
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INTRODUCTION
Vernonia amygdalina, Del (Asteraceae) is a tropical shrub, 1–3 m in 
height with dark green leaf petiole of about 6 mm in diameter, and 
elliptic in shape [1]. The leaves have characteristic odor and a bitter 
taste. The plant species is indigenous to tropical Africa and is found 
wild or cultivated all over Sub-Saharan Africa [2]. It is popularly called 
bitter leaf (English), oriwo (Edo, Nigeria), ewuro (Yoruba, Nigeria), 
shikawa (Hausa, Nigeria), and onugbu (Igbo, Nigeria) [3-5]. It is used 
traditionally by the Igbo speaking tribe of Nigeria to prepare famous 
“Onugbu soup” after squeezing out some of its bitterness with water. 
The leaves can be eaten raw after washing in the treatment of stomach 
ache.
All parts of the plant are pharmacologically useful. Both the roots 
and leaves are used in phytomedicine to treat fever, hiccups, kidney 
disease, and stomach discomfort [6,7]. Studies demonstrated 
the hypoglycemic and hypolipidemic effects of the leaf extract in 
experimental animals [5,8-10]. It has also been demonstrated to 
have antischistosomal, leishmanicidal, amebicidal, and plasmodial 
activity [11]. Masaba [12] also reported its involvement in ethno 
therapy of asthma, tuberculosis, measles, diarrhea, abdominal pain, 
and fever. Asuquo et al. [13], reported that V. amygdalina Del possessed 
cardioprotective potential in polytherapy with Ocimum gratissimum. 
Flavonoids contained in V. amygdalina have been identified as luteolin 
7-0-β glucoside [14]. These flavonoids have been demonstrated to have 
antioxidant activity [3]. Philipson et al.[15] reported the antiplasmodial 
effects of sesquiterpene and steroidal constituents of V. amygdalina 
and are also effective against Plasmodium falciparum in vitro. Teas 
containing bitter leaf (V. amygdalina) are also used throughout West 
Africa for the management of diabetes and other metabolic diseases 
associated with the liver [16,17]. The plant has acquired special 
relevance recently, having been proved in human medicine to possess 
potent antimalarial and antihelmintic properties [18], as well as 
antitumorigenic properties [19]. The sesquiterpene lactone extract 
from the leaves has antihepatotoxic activity in CCl4-induced hepatic 
damage in rats [20].
Recently, interest in the use of herbal remedies in the treatment of 
ailments is on the increase. A lot of efforts have been made to standardize 
herbal formulation by formulating them into various dosage forms [21-
24]. Herbal drugs are highly efficacious and are the source of some of 
the synthetic drugs known today. Hence, much research on natural 
or herbal drugs is worthwhile to encourage the use of these drugs 
worldwide. Standardization of herbal remedies is important to present 
these drugs in a dosage form that would be acceptable to patients, hence 
to improve acceptability, patients’ compliance and finally the efficacy 
of these remedies. Some of the herbal formulations are presented in 
capsules forms, as tablets, granules, in the form of tea bags, tonics, 
and macerates [21-24]. However, efforts have been made to formulate 
lipid-based delivery systems of herbal formulations [22]. These 
include solid lipid microparticles of Garcinia kola and Gongronema 
latifolium and in vivo studies in rats indicated higher absorption than 
the extracts [22]. Several companies are now involved in production 
and marketing of lipid-based herbal products Singha et al. [25]. Many 
popular herbal extracts including Ginkgo biloba, grape seed, hawthorn, 
olive fruits and leaves, ginseng, kushenin, marsupsin, and curcumin 
have been formulated as lipid-based formulations [25-27]. Increased 
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bioavailability of these formulations over the non-lipid complexed 
plant extract has been demonstrated by pharmacokinetics and activity 
studied in animals and humans [25-27].
Lipid-based formulations can be used to influence the absorption 
of active ingredients through different mechanisms to modify the 
release of active ingredients thus, improving bioavailability. Lipid 
formulations, in general, provide increased drug solubilization for 
water-insoluble drugs. If the drug is dissolved in the lipid matrix of 
the carrier, the drug absorption is observed to be better. The drug 
suspended in the lipid matrix has been shown to get absorbed better 
than the conventional solid dosage forms [28-30]. This could be due to 
the ease of wetting of the hydrophobic drug particles in the presence 
of lipid matrix [30].
Herbospheres are majorly solid lipid microparticles loaded with extracts 
of natural plants and have been investigated as a delivery system of 
G. kola and G. latifolium; results showed the taste masking potentials 
and also enhanced the oral bioavailability of the extracts [22]. The aim 
of the study is to encapsulate V. amygdalina extract in herbospheres 
using lipid matrix based on Phospholipon 90H and goat fat and to 
evaluate the antimicrobial properties of the formulations, in addition to 
taste masking and other in vitro properties.
METHODS
The following materials were procured from their local suppliers 
and used without modifications: Solutol® HS 15 (macrogol 15 
hydroxystearate - polyoxyl-15-hydroxystearate), Soluplus® (polyethylene 
glycol-polyvinyl caprolactam-polyvinylacetate copolymer) (BASF, 
Germany), Phospholipon® 90H (Phospholipid GmbH, köln, Germany), 
activated charcoal (Bio-Lab (UK) Limited, London), distilled water (STC 
UNN, Nigeria), methanol, sorbic acid, and sorbitol (Merck, Darmstadt, 
Germany).
Collection and identification of plant material
The fresh leaves of V. amygdalina (bitter leaf) were collected from Franco 
garden, University of Nigeria, Nsukka. The leaf was authenticated by Mr. 
A.O Ozioko, a consultant taxonomist with the International Center for 
Ethnomedicine and Drug Development (InterCEDD) Nsukka and the 
voucher specimen is deposited in the herbarium of the Department of 
Pharmacognosy and Environmental Medicine, University of Nigeria, 
Nsukka.
Extraction of V. amygdalina
V. amygdalina leaves were washed with water, dried under shade for 
7 days and subsequently milled using a blender (500# grinder/Fuyu 
Metal, Linyi Fuyu Metal Products Co., Ltd., China). The powdered leaf 
(290 g) was extracted by cold maceration using methanol as extracting 
solvent. The leaves were soaked in 1 L of analytical methanol for 
48 h with constant shaking in the first 6 h. The cold macerate was 
filtered using a muslin cloth embedded with cotton wool and attached 
to a filter funnel. The residue was discarded, and the filtrate was 
transferred into a stainless steel tray to evaporate the methanol and 
was allowed to dry. The percentage yield of the extract was found to 
be 11.0 6% [5].
EXTRACTION AND PURIFICATION OF GOAT FAT
The adipose tissues of Capra hircus were obtained from an abattoir 
in Nsukka market, Enugu, Nigeria. The adipose tissue was grated and 
subjected to moist heat by boiling with about half its weight of water in 
a water bath for 45 min. The molten fat was separated from the aqueous 
phase using a muslin cloth. Further purification was carried out by 
heating a 2% w/w suspension of a blend of activated charcoal and 
bentonite (1:19) in the lipid at 80°C for 1 h. Thereafter, the suspension 
was vacuum filtered using a Buchner funnel [31].
Phytochemical analysis
Phytochemical studies were carried out on the aqueous extract of bitter 
leaf for the presence of alkaloids, carbohydrates, saponins, reducing 
sugars, steroids, proteins, tannins, glycosides, terpenoids, flavonoids, 
resins, oils, and acid compounds using the standard procedures of 
analysis [32-34].
Preparation of lipid matrix carrier
The lipid matrix was prepared using the goat fat (70%) and Phospholipon 
90H, purified and completely hydrogenated soy phosphatidylcholine 
(30%) by fusion method. The lipids were melted together in a beaker 
using a magnetic stirrer hot plate (SR1 UM 52188, Remi Equip., India). 
It was stirred until they melted completely and was allowed to solidify.
Preparation of herbospheres
The herbospheres were prepared by melt homogenization using an 
Ultra-Turrax homogenizer (T25 Basic, Digital, Ika Staufen, Germany). 
Soluplus® and Solutol® HS 15 were used, respectively, as the surfactants, 
and the effect of the individual surfactants was studied. Details of the 
composition of the formulations are shown in Table 1. Sorbitol was used 
as a stable cryoprotectant, and sorbic acid was used as a preservative. 
The lipid matrix was melted using the magnetic stirrer hot plate, and the 
extract was dispersed in the molten lipid. A solution of sorbitol, sorbic 
acid, and the surfactant at the same temperature with the lipid was 
transferred into the dispersion of the extract and homogenized using 
an Ultra-Turrax homogenizer (T25 Basic, Digital, Ika Staufen, Germany) 
at 5000 rpm for 5 min. The herbospheres (o/w) were formed by phase 
inversion and were stored in an airtight bottle for further studies.
Characterization of Herbospheres
Analysis of taste of herbospheres
A panel consisting of 10 normal human volunteers with age range of 22–
48 years was used for taste evaluation of the herbospheres. Each volunteer 
was given 100 mL of the formulation and was retained in the oral cavity for 
2 min. After each determination, the oral cavity was rinsed with water and 
a washout period of 1 h was allowed between determinations. Response 






Particle size and morphology studies
Table 1: Composition of the herbospheres
Batch Extract (%) Lipid matrix (%) Sorbitol(%) Solutol® HS 15 (%) Soluplus® (%) Sorbic acid (%) Distilled water q. s (%)
A 1 5 4 0.75 - 0.05 100
B 3 5 4 0.75 - 0.05 100
C 5 5 4 0.75 - 0.05 100
D 1 5 4 - 0.75 0.05 100
E 3 5 4 - 0.75 0.05 100
F - 5 4 0.75 - 0.05 100
G - 5 4 - 0.75 0.05 100
Batches A, B, and C contain 1, 3, and 5% w/w of V. amygdalina extract, respectively, and Solutol, while batches D and E contain 1 and 3% w/w of crude extract, 
respectively, and Soluplus®. Batches F and G are bland herbospheres formulated with Solutol® and Soluplus®, respectively
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The particle size of the herbospheres was determined by computerized 
image analysis using a microscope (Wetzlar, Germany) attached with 
a digital image analyzer (Moticam, China). The particle diameter and 
the morphology were determined [31]. The mean particle size for each 
batch was calculated.
Analysis of encapsulation efficiency (EE) and loading capacity
Quantitative determination of the amount of extract encapsulated in each 
formulation was determined using ultraviolet (UV)-spectrophotometer 
(UNICO 2102 PC UV/Vis Spectrophotometer, USA) at a predetermined 
wavelength of 283 nm. A 10 mL quantity of the herbospheres was 
centrifuged at 1,252×g for 30 min (Chem. Lab. Instrument, UK). The 
supernatant was diluted and analyzed in a spectrophotometer (UNICO 
2102 PC UV/Vis Spectrophotometer, USA). The actual amount of extract 
encapsulated was determined by subtracting the actual mass extract in 
the supernatant (Wf) from the total amount of extract incorporated 
into the formulation (Wi).










Where Wl is the weight of lipid in the formulation, Wa is the weight 
of bitter leaf added to the formulation, and Ws is the actual amount of 
extract encapsulated (Ws = Wi - Wf) in the herbospheres.
Analysis of pH of herbospheres over time
The pH was determined using a pH meter (Suntex TS-2, Taiwan) at 1, 
7, and 30 days.
Inhibition zone diameter (IZD) test
The plate agar diffusion method was used for this study. Molten nutrient 
agar (20 mL) was inoculated with 0.1 mL of Staphylococcus aureus broth 
culture or Escherichia coli as the case may be. It was mixed thoroughly, 
poured into sterile Petri dishes and rotated for even distribution of 
the organism. The agar plates were allowed to set, and a sterile cork 
borer (8 mm diameter) was used to bore three cups in the seeded agar 
medium. Different concentrations (500, 250, and 125 mg/ml) of the 
herbospheres, bitter leaf extract, and tetracycline, respectively, were 
prepared. About 0.01 mL of each of the samples was added, into the 
different cups in each of the plates using Pasteur pipettes. The plates 
were allowed to stand at room temperature for 15 min to enable the 
samples to diffuse into the medium and lather incubated at 37°C for 
24 h. The IZD was measured [30].
Statistical analysis
Data were analyzed by one-way ANOVA. Differences between means 
were assessed using Student’s t-test, p<0.05 was considered significant.
RESULTS
Phytochemical constituents
The results of the phytochemical constituents of V. amygdalina leaf 
extract are shown in Table 2 and show that it contains alkaloids, 
carbohydrates, saponins, reducing sugars and steroids in very high 
concentrations, proteins, tannins, glycosides, terpenoids, flavonoids in 
moderate concentrations, and resins in low concentrations, while oils 
and acid compounds were absent.
Taste masking properties
The results of the taste masking potentials of herbospheres are shown 
in Table 3 and show that the extract was strongly bitter, while the bland 
formulations (F and G) were palatable. However, the herbospheres 
containing 1 and 3% of extracts (A, B, D, and E) were slightly bitter, while 
Batch C containing 3% of the extract was bitter. Therefore, herbospheres 
masked the terribly bitter taste of bitter leaf as shown in Table 3.
Particle size and morphology
The results of the particle morphology of herbospheres containing 
bitter leaf extract are shown in Fig. 1 and show that the particles 
were spherical in shape as expected for herbospheres. The results 
of particle size of herbospheres are shown in Fig. 2 and show that 
particle size increased with increase in amount of extract loaded in 
the herbospheres and ranged from 12.13±0.10 to 28.50±0.71 µm 
for batches A and C formulated with Solutol® as their surfactant and 
6.90±0.2 to 11.70±0.4 µm for batches E and D, respectively, containing 
3 and 1% of extract and Soluplus® as the surfactant.
The pH of the herbospheres
The results of the pH stability of the bitter leaf extract-loaded and 
unloaded herbospheres are shown in Fig. 3 and show that the pH of 
the bland (unloaded) formulations ranged from 6.3 to 4.4 at 1 and 
30 days for batch F, formulated with Solutol, while batch G containing 
Soluplus had pH of 6.4 and 4.7 at 1 and 30 days. The pH of the bitter leaf 
















+++: Highly concentration, ++: Moderate concentration, +: Low 
concentration, - Absent. V. amygdalina: Vernonia amygdalina
Table 3: Taste masking properties of V. amygdalina 
herbospheres
Batches Score Taste
A + Slightly bitter
B + Slightly bitter
C ++ Bitter
D + Slightly bitter
E + Slightly bitter
F 0 Palatable
G 0 Palatable
Extract (Et) +++ Strongly bitter
Batches A, B, and C contain 1, 3, and 5% w/w of crude extract of V. 
amygdalina respectively and Solutol®, while batches D and E contain 1 and 
3% w/w of the crude extract, respectively, and Soluplus®. Batches F and 
G are bland formulations containing Solutol® and Soluplus®, respectively. 
V. amygdalina: Vernonia amygdalina 
Fig. 1: (a and b) Photomicrographs of Vernonia amygdalina 
herbospheres containing 1% of extract; batches a and b were 
formulated with Solutol® and Soluplus®, respectively
a b
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herbospheres had pH of 5.6–5.9 at day 1 and 4.1–4.4 at 30 days. The 
results of bitter leaf herbospheres showed a significant decrease over 
time and remained in the acidic region from preparation to 30 days 
(p<0.05).
 EE and loading capacity
The results of the EE are shown in Fig. 4 and show that highest EE of 
90–92% was obtained for herbospheres loaded with 3 and 1% of bitter 
leaf extract and formulated with Soluplus as a surfactant. However, 
herbospheres containing Solutol had EE% range of 44 to 87% for 
batches C and B containing 5 and 3% of extract, respectively.
The results of the loading capacity of the lipid matrices are also 
shown in Fig. 4 and show that loading capacity increased with 
increase in the concentration of the extract loaded, with maximum 
LC of 64 mg extract/100 mg lipid matrix for batch C containing 5% 
of the extract.
Antimicrobial properties of bitter leaf herbospheres
The results of the IZD of the bitter leaf herbospheres are shown in Fig. 5 
and show that the herbospheres showed good antibacterial properties 
against Staph. aureus and E. coli. The results were comparable to that 
of the reference drug-tetracycline used for the studies. Bitter leaf 
herbospheres showed higher inhibition of Staph. aureus than E. coli (p 
< 0.05). Batches B and E showed significantly higher inhibition of Staph. 
aureus than tetracycline (p < 0.05).
DISCUSSION
The results of the phytochemical screening of bitter leaf indicated 
the presence of alkaloids, saponins, tannins, saponins, carbohydrates, 
reducing sugars, protein, steroids, flavonoids, and cardiac glycosides in 
substantial quantities. Acid compounds and oils were, however, absent. 
The presence of alkaloids in high concentration explains the traditional 
use of the plant for the treatment of malaria. The medicinal plants that 
are moderately rich in alkaloids and tannins have potential health-
promoting effects [35]. Similarly, saponins have anti-carcinogenic 
properties and other health benefits [22]. Alshawsh et al. [36] reported 
that tannins may have antiplasmodial activity. The stem bark of the 
plant also contains glycosides. Cardiac glycosides are used to treat heart 
problems that may result from a severe malaria attack. Phytochemicals 
are non-nutritive plant chemicals that have protective or disease 
preventive properties. Plants produce these chemicals substances 
to protect themselves, and they are also believed to protect humans 
against certain diseases [22].
The results of the taste masking properties of the herbospheres show that 
encapsulating bitter leaf extract into herbospheres significantly reduced 
the bitterness of this all-important herbal drug. This is particularly 
important because bitter leaf macerate, tonic or tea would be very 
Fig. 2: Particle size of bitter leaf extract-loaded herbospheres; 
batches A, B, and C contain 1, 3, and 5 % w/w of V. amygdalina 
extract, respectively, and Solutol®, while batches D and E contain 
1 and 3% w/w of extract and Soluplus®. Batches F and G are bland 
formulations with Solutol® and Soluplus®, respectively
Fig. 3: pH stability of Vernonia amygdalina leaf-extract 
herbospheres; batches A, B, and C contain 1, 3, and 5% w/w of 
V. amygdalina extract, respectively, and Solutol® while batches D 
and E contain 1 and 3% w/w of crude extract, respectively, and 
Soluplus® as a surfactant. Batches F and G are bland formulations 
with Solutol® and Soluplus®, respectively
Fig. 4: Encapsulation efficiency and loading capacity of Vernonia 
amygdalina leaf-extract herbospheres; batches A, B, and C contain 
1, 3, and 5% w/w of V. amygdalina extract, respectively, and 
Solutol® while, batches D and E contain 1 and 3% w/w of extract, 
respectively, and Soluplus® as a surfactant.
Fig. 5: Antimicrobial properties of Vernonia amygdalina leaf-extract 
herbospheres; batches A, B, and C contain 1, 3, and 5% w/w of V. 
amygdalina extract, respectively, and Solutol® while, batches D and 
E contain 1 and 3% w/w of extract, respectively, and Soluplus®; 
TN: Tetracycline, Et: Extract
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difficult for any patient to swallow; therefore, this herbal remedy is best 
administered as an encapsulated dosage form. Encapsulating of herbal 
formulation into solid lipid microparticles has been shown to mask the 
bitter properties of the extract and also enhance oral bioavailability [30]. 
Therefore, this novel herbospheres formulation strategy would enhance 
patient compliance in addition to enhanced bioavailability.
The particle size of the herbospheres was found to lie within micrometer 
range and agrees with the results of previous works [22]. Particle size 
significantly increased with the incorporation of the drug compared 
to the bland formulations (p<0.05). However, the increase was not 
proportional to the quantity of extract loaded as shown by batch E 
containing 3% of extract which showed smaller particle size than batch D 
containing 1% of the extract. The results also varied significantly within 
the sub-batches with batch C showing the highest mean particle size of 
28.5 µm (p<0.05). The photomicrographs of the solid lipid microspheres 
revealed that they are crystalline in nature, spherical and have uniform 
smooth surface. Particle size was significantly affected by the type of 
surfactant used (p<0.05). Batches A, B, and C formulated with Solutol® 
had higher particle sizes than batches C and D formulated with Soluplus®.
The results of the pH of the herbospheres showed a significant decline 
in storage (p<0.05). However, the bland formulations also showed a 
significant decline in pH suggesting that pH decrease may be due to 
release of free fatty acids from the individual lipids. Therefore, pH decline 
was not due to degradation of encapsulated extract since there was also 
a corresponding decrease in the pH of the unloaded formulations.
The results of EE% of the herbospheres show that the formulations 
generally exhibited high EE. However, the EE of the herbospheres 
was affected by the type of surfactant used. Herbospheres formulated 
with Soluplus® generally exhibited higher EE% than those formulated 
with Solutol®. The Soluplus® being a copolymer of polyethylene 
glycol-polyvinyl caprolactam-polyvinyl acetate had higher surface 
tension reduction effect than Solutol® which is macrogol 15 
hydroxystearate - polyoxyl-15-hydroxystearate, hence enhanced 
encapsulation of the extract.
The results of the loading capacity of the lipid matrix showed that LC 
increased with increase in the loading of the extract in agreement with 
previous researches [30].
The in vitro antimicrobial properties of the herbospheres show that 
bitter leaf extract formulations exhibited significantly higher inhibition 
of S. aureus than tetracycline pure sample used as the reference drug. 
The activities were, however, comparable to that of the extract against 
S. aureus and E. coli. The results show that the formulations had good 
antibacterial properties in addition to taste masking potentials. These 
results also revealed that the active constituents in the extract were not 
denatured by the processes of formulations and/or the excipient used 
in the formulation.
CONCLUSION
Herbospheres is a novel and efficient drug delivery system for 
herbal drugs. The advantages of presenting herbal drugs inform 
of herbospheres include enhanced palatability, improve patient 
acceptability of herbal formulations due to enhanced esthetic appeal 
and taste masking, better disease management due to improvement 
in patient compliance and improve bioavailability due to enhanced 
absorption caused by the presence of surfactants in the formulations 
and presence of lipids. This formulation approach should be scaled up 
to further encourage the use of the natural drug as a curative in the 
treatment of diseases.
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